pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 607 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    pexastimogene devacirepvec
    pexastimogene devacirepvec
    Metastatic Renal Cell Carcinoma Sillajen Biotherapeutics
  • Phase 2
    pifusertib
    pifusertib [INN]
    Solid Tumor Taiho Pharmaceutical Co Ltd
  • Phase 2
    plixorafenib
    plixorafenib
    Central Nervous System (CNS) Tumor Fore Biotherapeutics Inc
  • Phase 2
← prev
page 18 of 21
next →
131
Pain89
Neurology1
plogosertib
plogosertib [INN]
Bladder Cancer
Tethra Biosciences Inc
  • Phase 2
    pocenbrodib hydrochloride
    pocenbrodib hydrochloride
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Pathos AI Inc
  • Phase 2
    podentamig
    podentamig [INN]
    Refractory Multiple Myeloma$MRK Merck & Co., Inc.
  • Phase 2
    polzastobart
    polzastobart
    Cutaneous Squamous Cell Carcinoma (cSCC) Concentra Biosciences LLC
  • Phase 2
    prexasertib mesylate monohydrate
    prexasertib mesylate monohydrate
    Endometrial Cancer$ACRV Acrivon Therapeutics, Inc.
  • Phase 2
    prexigebersen
    prexigebersen
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$BPTH BIO-PATH HOLDINGS, INC.
  • Phase 2
    prizloncabtagene autoleucel
    prizloncabtagene autoleucel [INN]
    Diffuse Large B-Cell Lymphoma Janssen Biotech Inc
  • Phase 2
    quaratusugene ozeplasmid
    Reqorsa (quaratusugene ozeplasmid)
    Non-Small Cell Lung Cancer$GNPX Genprex, Inc.
  • Phase 2
    radgocitabine
    radgocitabine [INN]
    Refractory Acute Myeloid Leukemia Delta-Fly Pharma Inc
  • Phase 2
    relatlimab
    relatlimab
    Metastatic Hepatocellular Carcinoma (HCC) Bristol-Myers Squibb Co
  • Phase 2
    remetinostat
    remetinostat
    Cutaneous T-Cell Lymphoma Biossil Inc
  • Phase 2
    rencofilstat
    rencofilstat
    Hepatocellular Carcinoma$HEPA Hepion Pharmaceuticals, Inc.
  • Phase 2
    resiquimod
    resiquimod
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B… SURGE Therapeutics Inc
  • Phase 2
    resiquimod sulfate
    resiquimod sulfate
    Squamous Non-Small Cell Lung Cancer$EIKN Eikon Therapeutics, Inc.
  • Phase 2
    rezatapopt
    rezatapopt
    Bile Duct Cancer (Cholangiocarcinoma)$PMVP PMV Pharmaceuticals, Inc.
  • Phase 2
    rhenium (186Re) obisbemeda
    Reyobiq (rhenium (186Re) obisbemeda)
    Malignant Glioma$PSTV PLUS THERAPEUTICS, INC.
  • Phase 2
    rigosertib sodium
    rigosertib sodium
    Non-Small Cell Lung Cancer$TRAW Traws Pharma, Inc.
  • Phase 2
    rintatolimod
    Ampligen (rintatolimod)
    Epithelial Ovarian Cancer$AIM AIM ImmunoTech Inc.
  • Phase 2
    roginolisib
    roginolisib [INN]
    Metastatic Uveal Melanoma iOnctura SA
  • Phase 2
    rogocekib
    rogocekib [INN]
    Chronic Myelomonocytic Leukemia (CMML) Chordia Therapeutics Inc
  • Phase 2
    rondecabtagene autoleucel
    rondecabtagene autoleucel [INN]
    Diffuse Large B-Cell Lymphoma$LYEL Lyell Immunopharma, Inc.
  • Phase 2
    rose bengal sodium
    rose bengal sodium [INN]
    Metastatic Melanoma$PVCT PROVECTUS BIOPHARMACEUTICALS, INC.
  • Phase 2
    rosopatamab tetraxetan
    rosopatamab tetraxetan [INN]
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Convergent Therapeutics Inc
  • Phase 2
    roxadustat
    roxadustat
    Myelodysplastic Syndrome (Preleukemia)$KYNB KYNTRA BIO, INC.
  • Phase 2
    ruxotemitide
    Oncopore (ruxotemitide [INN])
    Metastatic Melanoma Lytix Biopharma ASA
  • Phase 2
    sacituzumab drozuntecan
    sacituzumab drozuntecan [INN]
    Epithelial Ovarian Cancer$BNTX BioNTech SE
  • Phase 2
    sapablursen sodium
    sapablursen sodium
    Polycythemia Vera Ono Pharmaceutical Co Ltd